Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (8744)	2/16/1999 2:26:00 PM
From: Bluegreen	Read Replies (2) \| Respond to of 17367

I'm trying to say Xoma has a safe product with kids dying around OUR country not only the UK. What if it only worked 1 out of a thousand times? Are you prepared to tell your kid he or she can't have it IF that kid is going down the tubes despite all conventional therapies? Why, the FDA can't even play benefit risk ratio with Neuprex because of its safety record. George, if there was an activist group behind Neuprex we wouldn't be arguing. Remember this is life and death for these kids, even if you saved one out of a hundred or even a thousand, it would be the RIGHT thing to do. Sure it would be expensive but so is vaccinating huge amounts of kids. Hopefully even in this day and age of Clinton this country still knows what doing the right thing means. Only my opinions.